About: dbpedia:Panitumumab   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : platform.yourdatastories.eu:8890 associated with source document(s)

Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).Panitumumab is manufactured by Amgen and marketed as Vectibix. It was originally developed by Abgenix Inc.In 2014, Amgen and Illumina entered into an agreement to develop a companion diagnostic to accompany panitumumab.

AttributesValues
rdfs:comment
  • Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).Panitumumab is manufactured by Amgen and marketed as Vectibix. It was originally developed by Abgenix Inc.In 2014, Amgen and Illumina entered into an agreement to develop a companion diagnostic to accompany panitumumab.
ATC prefix
  • L01
ATC suffix
  • XC08
CAS number
  • 339177-26-3
DrugBank
  • DB01269
FDA UNII code
  • 6A901E312A
is product of
Faceted Search & Find service v1.13.91 as of Nov 14 2017


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3212 as of Mar 29 2016, on Linux (x86_64-unknown-linux-gnu), Single-Server Edition (68 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2026 OpenLink Software